ReviewYonsei medical journal2008
Pleural epithelioid hemangioendothelioma.
Review in Yonsei medical journal, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- Case Report: The first account of primary myeloid sarcoma of the testis combined with ipsilateral epididymal epithelioid hemangioendothelioma.Frontiers in medicine · 2025Article
- Epithelioid Hemangioendothelioma (EHE) Mimicking Mesothelioma: Case Presentation and Review.Case reports in oncological medicine · 2025Article
- Pleural epithelioid hemangioendothelioma in a 39-Year-old female: a case report.Journal of cardiothoracic surgery · 2024Article
- Rare cancer with primary pleural epithelioid hemangioendothelioma diagnosed by thoracoscopic biopsy achieving disease control after 16 months: case report and literature review.Frontiers in pharmacology · 2024Article
- Primary pulmonary epithelioid hemangioendothelioma.BMJ case reports · 2023Article
- Article
- Pleural Neoplasms-What Could MRI Change?Cancers · 2023Review
- Primary malignant epithelioid hemangioendothelioma of the pleura: A review and report of a novel case.Clinical case reports · 2022Article
- Epithelioid hemangioendothelioma: evaluation byAmerican journal of nuclear medicine and molecular imaging · 2021Article
- Epithelioid hemangioendothelioma of spine: A case report with review of literatures.Radiology case reports · 2020Article
- Epithelioid hemangioendothelioma of the sternum.Thoracic cancer · 2020Article
- Difficulty of treatment for pleural epithelioid hemangioendothelioma: a report of a case.General thoracic and cardiovascular surgery · 2020Article
- Pleural epithelioid hemangioendothelioma mimicking pleural empyema: A case report.Respiratory medicine case reports · 2020Article
- Metastatic Hepatic Epithelioid Hemangioendothelioma Treated with Olaratumab: A Falling Star Rising?Therapeutics and clinical risk management · 2020Article
- [Research Progress of Pulmonary Epithelioid Hemangioendothelioma].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2019Review
- Article
- Pleural epithelioid hemangioendothelioma: literature summary and novel case report.Journal of clinical medicine research · 2015Article
- A rare case of intravascular epithelioid hemangioendothelioma of the cephalic vein treated with surgery and postoperative radiation therapy: a case report and review of the literature.Journal of medical case reports · 2015Review
- Eight years tumor control with pazopanib for a metastatic resistant epithelioid hemangioendothelioma.Clinical sarcoma research · 2015Article
- Epithelioid hemangioendothelioma: an overview and update on a rare vascular tumor.Oncology reviews · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epithelioid hemangioendothelioma (EHE) is a rare tumor of vascular origin. While it can be found in any tissue, it is most often found in lung and liver and usually has an intermediate behavior. EHEs originating from pleural tissue have been less frequently described than those from other sites. Furthermore, to date, all of the cited pleural EHEs were described as highly aggressive. In the present report, we describe a rare case of pleural EHE extending to lung and bone in a 31-year-old woman. The histological diagnosis was confirmed by both conventional examination and immunohistochemistry. Her disease stabilized during the 4th course of adriamycin (45 mg/m(2), day 1-3), dacarbazine (300 mg/m(2), day 1-3) and ifosfamide (2,500 mg/m(2), day 1-3) with mesna, and she survived for 10 months after the diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.